United States
Germany
Japan
United Kingdom
China
SAP30 (NM_003864) Human Tagged ORF Clone Lentiviral Particle
CAT＃: RC203160L1V
- LentiORF®
-
Lenti ORF particles, SAP30 (Myc-DDK tagged) - Human Sin3A-associated protein, 30kDa (SAP30), 200ul, >10^7 TU/mL
Need custom lentivirus service?
Get a free quote
CNY 7,410.00
货期*
详询
规格
Product images
经常一起买 (3)
Specifications
| Product Data | |
| Product Name | SAP30 (NM_003864) Human Tagged ORF Clone Lentiviral Particle |
| Vector | pLenti-C-Myc-DDK |
| ACCN | NM_003864 |
| ORF Size | 660 bp |
| Sequence Data |
The ORF insert of this clone is exactly the same as(RC203160).
|
| OTI Disclaimer | The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info |
| OTI Annotation | This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. |
| Reference Data | |
| RefSeq | NM_003864.3 |
| RefSeq Size | 1126 bp |
| RefSeq ORF | 663 bp |
| Locus ID | 8819 |
| Protein Families | Druggable Genome, Transcription Factors |
| MW | 23.1 kDa |
| Gene Summary | Histone acetylation plays a key role in the regulation of eukaryotic gene expression. Histone acetylation and deacetylation are catalyzed by multisubunit complexes. The protein encoded by this gene is a component of the histone deacetylase complex, which includes SIN3, SAP18, HDAC1, HDAC2, RbAp46, RbAp48, and other polypeptides. This complex is active in deacetylating core histone octamers, but inactive in deacetylating nucleosomal histones. A pseudogene of this gene is located on chromosome 3. [provided by RefSeq, Jul 2008] |
Documents
| Product Manuals |
| FAQs |
| SDS |
Resources
You may also need
Customer
Reviews
Loading...
